Visalytics
Visalytics
approved EB-2 (NIW)

Internal Medicine Resident

Substance Use Disorder · China · 2025-10-31

Processing Time
57 days
Decision Date
2025-10-31
Location
Maryland
This case is from a publicly available case study. Case studies tend to feature successful outcomes and may not reflect the full range of petition results.

Proposed Endeavor

The petitioner proposes to conduct research focused on improving the understanding and management of substance use disorders through population-based data analysis. The work involves evaluating treatment outcomes, disparities, and the broader public health impact of addiction to support effective healthcare delivery and policy interventions.

Framework Evaluation

3 of 3 criteria met
1 Substantial Merit and National Importance Met

The endeavor addresses the critical national public health and social challenges posed by substance use disorders.

2 Well-positioned to Advance the Endeavor Met

The petitioner's record of 5 peer-reviewed publications and 65 citations demonstrates a proven capacity to contribute to the field.

3 Waiver Benefit to the US Met

On balance, the petitioner's data-driven research on addiction treatment and health equity justifies waiving the labor certification requirement.

Why This Petition Was Approved

The petition was approved based on the petitioner's research record of five peer-reviewed journal articles and one conference abstract, which garnered 65 citations from independent researchers. The case successfully satisfied the Matter of Dhanasar framework by demonstrating the national importance of addiction research and the petitioner's capacity to contribute independently. The rapid approval in 57 days via premium processing further reflects the strength of the evidence submitted.

Evidence

Evidence Types
Peer Reviewed Publications
Citations
Conference Presentations
Original Contributions
Government Alignment

Similar Cases

Epidemiologist

Healthcare · Nepal

WeGreened EB-2 (NIW) approved
Florida 89 days 2023-02-26
The petitioner proposes to continue his research on identifying at-risk persons and underlying factors contributing to substance abuse through advanced epidemiological studies and statistical analysis. This work aims to control the long-term health, social, and economic burdens associated with addiction and chronic tobacco use in the United States.
View Case

Others

Biotechnology · India

WeGreened EB-2 (NIW) rfe approved
Virginia 180 days 2023-03-31
The petitioner proposes to focus on pre-clinical toxicity studies of novel small molecules and the safety monitoring of pharmaceutical therapies for conditions including alcohol and opioid dependence, schizophrenia, bipolar disorder, cancers, and neurodegenerative disorders. This work aims to develop viable new drug treatments and reduce preclinical trial costs.
View Case

Research Scientist

Pharmaceuticals · China

WeGreened EB-2 (NIW) approved
Illinois 110 days 2023-02-02
The petitioner proposes to conduct research combining pharmacoepidemiology, pharmacoeconomics, and health outcomes science to identify treatment risks and prescribing patterns. Her work focuses on uncovering disease mechanisms and patient outcomes in chronic conditions like COPD, liver disease, and breast cancer to inform better diagnostic and therapeutic strategies. The endeavor aims to improve healthcare delivery efficiency and public health innovation within the United States.
View Case

Research Scientist

Healthcare · China

WeGreened EB-2 (NIW) approved
New York 352 days 2025-10-01
The petitioner proposes to employ robust epidemiological studies and statistical methods to investigate urgent public health issues, specifically focusing on prescription drug use, cancer prevention, and treatment. The work aims to generate accessible guidelines for public health researchers, physicians, and government agencies to improve population health outcomes.
View Case

Frequently Asked Questions

A approved EB-2 NIW (I-140) petition means USCIS determined the petitioner met the eligibility requirements. For appealed cases, "sustained" means the appeal reversed a prior denial. The petitioner can proceed to the next step in the immigration process.

Browse More Cases

More approved cases More Healthcare cases More cases from China

Case data sourced from publicly available petition decisions and case studies. Decision date: 2025-10-31.

Browse all cases
View Original

At a Glance

Outcome approved
Processing 57 days
Criteria Met 3 / 3
Evidence Types 5

EB-2 (NIW) Case Data

Scraped Case Data

Total Cases 3,816
Success Rate 53.6%
Sustained 2,046
Dismissed 1,674

Related Pages

EB-2 (NIW) Overview EB-2 (NIW) in China All EB-2 (NIW) Cases EB-2 (NIW) Dashboard Endeavor Search

Get Case Insights

Compare your profile against thousands of real petition outcomes. Join the waitlist for personalized analysis.

Join Waitlist